COL4A1 and COL4A2 mutations can induce neurological diseases, including epilepsy (Zagaglia et al., 2018), hemorrhagic stroke (Jeanne et al., 2012)], and sporadic cerebral small vessel disease (Rannikmäe et al., 2015). Here, COL4A1 is linked to epilepsy.